Linked Life Data

2100046

Source:http://linkedlifedata.com/resource/pubmed/id/2100046

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1991-8-14
pubmed:abstractText
Apomorphine is a powerful dopaminergic drug, able to improve cardinal symptoms of Parkinson's disease in few minutes, when injected subcutaneously. We administered different doses of apomorphine s.c. against placebo in 25 patients with a Parkinsonian syndrome, with the aim of discriminating Parkinson's disease from other Parkinsonism. A positive response to apomorphine was predictive (88%) of good responsiveness to levodopa therapy. Our data, together with those of other groups, indicate that apomorphine test is a useful tool in the diagnosis of Parkinsonian syndromes.
pubmed:language
ita
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0035-6344
pubmed:author
pubmed:issnType
Print
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
221-3
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
[The apomorphine test for diagnosis of parkinsonian syndrome].
pubmed:affiliation
Istituto di Clinica Neurologica, Università di Pisa.
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract, Controlled Clinical Trial